Attovia (ATTO) Director You Angie Receives 27,000-Share Award

What Happened

• You Angie, a director of Attovia Therapeutics, was granted a derivative award covering 27,000 shares on August 4, 2026. The grant price is reported as $0.00 (no cash paid at grant); the filing classifies this as an award/derivative transaction rather than an open-market purchase or sale.

Key Details

• Transaction date: August 4, 2026; Form 4 filed August 6, 2026 (filed within the standard two-business-day window).
• Price: $0.00 per share (grant/derivative award).
• Shares acquired: 27,000 (derivative securities).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnote: The award vests in full on the earlier of (i) August 4, 2027 and (ii) the next annual meeting of stockholders, subject to continued service (see footnote F1).
• Filing timeliness: Appears timely (filed two days after the transaction).

Context

• This was a compensation grant (derivative award) rather than a market purchase or sale. For derivative awards, vesting conditions and continued service requirements determine when the insider actually gains control of the underlying shares. The filing does not indicate any immediate sale of shares.